Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Sioux City, IA-NE-SD MSA — September 2026
Sioux City clinical pay surges as biostatistician wages lag national trend.
Metro Clinical Research Associate pay has climbed to $106,222 against a $90,956 national median, even as local biostatistician pay fell to $110,253 while the national figure rose to $133,322.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro CRA advertised pay: $106,222 — vs $90,956 national median, up significantly
- Metro biostatistician pay: $110,253 — down vs national median of $133,322, rising
- Sioux City MSA unemployment: 3.2%-3.8% — Iowa statewide at 3.2%, 4th month unchanged
- Metro nonfarm employment change: -1.2% YoY — Through Feb 2026, despite low unemployment
Key takeaways
Clinical Research Associate pay is outrunning the national market.
Metro CRA advertised pay sits at $106,222 versus $90,956 nationally, a premium that appears to reflect genuine scarcity rather than typical cost-of-living adjustment in a metro this size. Compensation benchmarking for clinical functions should account for local talent tightness, not just national surveys.
Biostatistician pay is falling locally while rising nationally.
Metro biostatistician pay dropped to $110,253 even as the national median climbed to $133,322, a divergence that may signal thinner local demand or a smaller, less competitive hiring pool for this role. Employers recruiting biostatisticians from outside the metro should expect resistance if local postings undervalue the role relative to national market movement.
Lab Technician wages are softening in a tightening labor market.
Metro lab tech pay fell to $44,656, tracking a broader national decline to $47,402, even as overall metro unemployment stays near historic lows. Falling entry-level technical pay alongside low unemployment is consistent with employers relying more on automation or outsourcing lab functions rather than competing harder for local technician talent.
Shrinking labor supply, not soft demand, is the real constraint.
Total nonfarm employment fell 1.2% year-over-year even as unemployment held in the low 3% range, indicating workers are exiting the labor force rather than sitting idle. Iowa's statewide working-age population decline, driven partly by retirement, compounds this for life sciences employers who depend on specialized, hard-to-replace scientific staff.
Median advertised pay by role — Sioux City, IA-NE-SD MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $74,181 | $104,805 | $112,429 | Significant increase | $131,354 |
| Clinical Research Associate * | $57,200 | $106,222 | $125,628 | Significant increase | $90,956 |
| Lab Technician * | $39,439 | $44,656 | $48,378 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $74,639 | $90,187 | $103,011 | Significant increase | $104,000 |
| Clinical Data Manager * | $74,125 | $89,187 | $112,693 | Significant decline | $123,031 |
| Biostatistician * | $86,372 | $110,253 | $146,269 | Moderate decline | $133,322 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Sioux City metro unemployment held near 3.2%-3.8% through mid-2026 even as total nonfarm employment declined 1.2% year-over-year through February, a combination that signals a shrinking labor pool rather than a cooling demand for talent. Manufacturing posted 1.3% annual growth and government employment rose 3.4%, while leisure and hospitality contracted — leaving scientific, technical, and manufacturing-adjacent life sciences employers competing for a smaller pool of workers inside an already tight 3.2% statewide unemployment environment.
What it means
Thin local bench strength for specialized scientific, regulatory, and manufacturing talent makes outsourcing to CROs and CDMOs increasingly attractive for Sioux City-area biotech, pharma, and device employers, particularly where Iowa's limited biotech concentration (Boehringer Ingelheim Vetmedica, Lumos Pharma) already caps internal pipeline depth. Clinical Research Associate advertised pay in the metro has moved up sharply to a $106,222 median — well above the $90,956 national figure — suggesting local employers are paying a premium to secure clinical talent that would otherwise leave for larger biotech hubs. Organizations should evaluate whether build-vs-outsource tradeoffs for clinical and CMC functions now favor contract specialists given how far local CRA pay has diverged from national norms.
Looking ahead
Expected: September 2026 BLS employment data for the Sioux City MSA releases in early October with a one-month lag; watch whether the 1.2% year-over-year employment decline persists or stabilizes, particularly in manufacturing and government, Iowa's two growth sectors.
Emerging pressure point: Iowa's new Career Training Physical Expansion Grants (effective September 15) target apprenticeship capacity for mid-skill manufacturing and QA technician pipelines — a potential medium-term offset to local lab technician and bioprocess technician shortages worth tracking for build-vs-buy manufacturing decisions.
Worth watching: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while execution-critical roles stay open; monitor whether any displaced regulatory, CMC, or clinical talent relocates toward lower-cost Midwest metros like Sioux City.
Potential inflection point: Healthcare employment in Iowa grew 5,700 jobs year-over-year and competes directly with life sciences for clinical and regulatory talent; sustained healthcare hiring strength could further tighten the already thin pool of credentialed professionals available to biotech and device employers in the metro.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.